IBM is moving forward with a $2 billion expansion in New York to develop a new AI center, according to a report published in The Washington Post.

Medical imaging is in a big battle with big data. There’s too much data in too many locations, and most often they are not well managed. Data are clearly imaging’s most abundant yet most underutilized strategic asset. 

A recent win by DeepMind, an AI lab owned by Google parent company Alphabet, in a protein-folding problem competition has scientists wondering how the technology can change the drug discovery industry, according to a report by The New York Times.

Walmart is allowing its employees to see a provider for only $4 but the visitation has to be through telemedicine, according to a report from the Associated Press.

Amid a major period of consolidation in the healthcare space, health systems have grown so large that using a patient’s name or date of birth isn’t a good identifier anymore. Instead, hospitals are turning to biometric systems, which use fingerprints or other physical characteristics to identify people, The Wall Street Journal reported.

An AI algorithm helped determine adult women’s brains are, on average, a few years younger than the brains of males of the same age, according to research published in the Proceedings of the National Academy of Sciences.

Mayo Clinic has teamed up with Fortune 500 company Leidos in a strategic collaboration to develop and market tools, technologies and therapeutics to engage patients and families in their care.

Reuters reports the Trump administration will take executive action in the next few weeks to ensure the U.S. keeps abreast of research and development opportunities in “industries of the future”—including AI and 5G networks.